ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 941,91
-1,31%
Dow Jones
41 737,34
-0,42%
DAX
22 328,77
-1,23%
Brent Oil
69,635
0,86%
Bitcoin
83 240,99
6,08%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. Coherus BioSciences Inc (CHRS) Cours

Coherus BioSciences Inc

Coherus BioSciences Inc (CHRS)

NASDAQ
1,05
0,01
( 0,96% )
Mis à jour : 19:39:58
Retardé de 15 minutes

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Premium

Statistiques et détails clés

Dernier
1,05
Prix Achat
1,04
Prix Vente
1,05
Volume échangé
1 909 276
0,9501 Fourchette du Jour 1,121
0,6655 Plage de 52 semaines 2,64
Cap du marché
120,974M
Clôture Veille
1,04
Ouverture
1,04
Dernière Transaction
100
@
1.05
Dernière heure de transaction
19:41:31
Volume financier
US$ 2 022 626
VWAP
1,0594
Volume moyen (3 m)
1 933 717
Actions en circulation
115 213 407
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-0,50
Bénéfice par action (BPA)
-2,06
Chiffre d'affairess
257,24M
Bénéfice net
-237,89M

À propos de Coherus BioSciences Inc

Coherus BioSciences Inc is a commercial-stage biopharmaceutical company building an innovative immuno-oncology franchise funded with cash generated by its diversified portfolio of FDA-approved therapeutics. Toripalimab is being evaluated in pivotal clinical trials for the treatment of cancers of the... Coherus BioSciences Inc is a commercial-stage biopharmaceutical company building an innovative immuno-oncology franchise funded with cash generated by its diversified portfolio of FDA-approved therapeutics. Toripalimab is being evaluated in pivotal clinical trials for the treatment of cancers of the lung, breast, liver, skin, kidney, stomach, esophagus, and bladder. The company markets UDENYCA, a biosimilar of Neulasta in the United States, and expects to launch the FDA-approved Humira biosimilar YUSIMRY in the United States in 2023. The company is also developing CHS-305, a biosimilar of Avastin. The company generates revenue primarily from the United States. Show more

Secteur
Biological Pds,ex Diagnstics
Industrie
Biological Pds,ex Diagnstics
Site Web
www.coherus.com
Siège social
Wilmington, Delaware, USA
Fondé
-
Coherus BioSciences Inc est coté dans le secteur Biological Pds,ex Diagnstics de la NASDAQ avec le ticker CHRS. Le dernier cours de clôture d'Coherus BioSciences était de US$1,04. Au cours de la dernière année, les actions de Coherus BioSciences ont été négociées dans une fourchette de prix de US$ 0,6655 à US$ 2,64.

Coherus BioSciences compte actuellement 115 213 407 actions en circulation. La capitalisation boursière d'Coherus BioSciences est de US$119,82 million. Coherus BioSciences a un ratio cours/bénéfice (ratio PE) de -0.50.

CHRS Dernières nouvelles

Plus de nouvelles

Form 8-K - Current report
Edgar (US Regulatory)
il y a 22 heures
CHRS (0,96%)

Form 8-K - Current report
Edgar (US Regulatory)
04 Mars 2025
CHRS (0,96%)

Form DEFM14A - Definitive proxy statement relating to merger or acquisition
Edgar (US Regulatory)
28 Janvier 2025
CHRS (0,96%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
23 Janvier 2025
CHRS (0,96%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
23 Janvier 2025
CHRS (0,96%)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10.043.96039603961.011.180.950119774031.03289389CS
4-0.1-8.695652173911.151.210.950114690771.07994489CS
12-0.58-35.58282208591.631.76990.950119337171.29755341CS
26-0.31-22.79411764711.362.430.665536330371.30999603CS
52-1.32-55.69620253162.372.640.665527086501.49855596CS
156-11.53-91.65341812412.5814.110.665525618323.5468791CS
260-16.01-93.845252051617.0622.21660.665519278246.25724706CS

CHRS - Frequently Asked Questions (FAQ)

What is the current Coherus BioSciences share price?
The current share price of Coherus BioSciences is US$ 1,05
How many Coherus BioSciences shares are in issue?
Coherus BioSciences has 115 213 407 shares in issue
What is the market cap of Coherus BioSciences?
The market capitalisation of Coherus BioSciences is USD 119,82M
What is the 1 year trading range for Coherus BioSciences share price?
Coherus BioSciences has traded in the range of US$ 0,6655 to US$ 2,64 during the past year
What is the PE ratio of Coherus BioSciences?
The price to earnings ratio of Coherus BioSciences is -0,5
What is the cash to sales ratio of Coherus BioSciences?
The cash to sales ratio of Coherus BioSciences is 0,46
What is the reporting currency for Coherus BioSciences?
Coherus BioSciences reports financial results in USD
What is the latest annual turnover for Coherus BioSciences?
The latest annual turnover of Coherus BioSciences is USD 257,24M
What is the latest annual profit for Coherus BioSciences?
The latest annual profit of Coherus BioSciences is USD -237,89M
What is the registered address of Coherus BioSciences?
The registered address for Coherus BioSciences is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Coherus BioSciences website address?
The website address for Coherus BioSciences is www.coherus.com
Which industry sector does Coherus BioSciences operate in?
Coherus BioSciences operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
RAYRaytech Holding Ltd
US$ 1,741
(100,11%)
92,65M
SYRSSyros Pharmaceuticals Inc
US$ 0,166
(81,22%)
663,61M
TSVT2seventy bio Inc
US$ 4,95
(76,79%)
29,65M
SPHLSpringview Holdings Ltd
US$ 6,16
(50,98%)
962,47k
TNONTenon Medical Inc
US$ 1,85
(48,00%)
33,59M
WCTWellchange Holdings Company Limited
US$ 0,6766
(-73,04%)
31,13M
ARVNArvinas Inc
US$ 8,5962
(-51,05%)
14M
LZMHLZ Technology Holdings Ltd
US$ 7,925
(-49,39%)
586,44k
SPGCSacks Parente Golf Inc
US$ 0,1039
(-35,10%)
32M
HTCOHigh Trend International Group
US$ 1,61
(-24,41%)
150,27k
SYRSSyros Pharmaceuticals Inc
US$ 0,1659
(81,11%)
663,64M
BHATBlue Hat Interactive Entertainment Technology
US$ 0,0383
(14,33%)
390,27M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 8,0408
(8,95%)
258,96M
NVDANVIDIA Corporation
US$ 110,15
(2,96%)
258,75M
CUTRCutera Inc
US$ 0,1088
(-15,33%)
210,1M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
CHRS
Coherus BioSciences
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces